XTLB: XTL Bio Sotuvga nisbatan narx
XTL Biopharmaceuticals kelajakdagi narxlarni belgilash imkoniyatiga tayanib, autoimmun patologiyalarga qarshi kurashish uchun terapiyalarni ishlab chiqmoqda. Bozor kapitalizatsiyasining daromadga nisbati bozor baholashini tasdiqlaydi, bunda 12.70 qiymati joriy ko'rsatkich vazifasini o'taydi. Kompaniya marjalarni himoya qilish uchun immunologik xomashyo ta'minot zanjirlarini optimallashtirmoqda, shu bilan birga tibbiy IT yechimlari va tayyor tijorat ishlanmalarini integratsiya qilish orqali aktivlar portfelini qayta tuzmoqda.
XTL Biopharmaceuticals, Ltd. (XTLB) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati XTL Bio|XTLB - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati XTL Biopharmaceuticals, Ltd.|XTLB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi XTL Biopharmaceuticals|Shoshilinch likvidlik xtlbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
XTLB - Kompaniyaning sof foydasi|Forvard foyda XTL Biopharmaceuticals|XTLB - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori XTL Biopharmaceuticals Ltd|XTLB - PEG multiplikatori|EV/EBITDA multiplikatori XTL Biopharmaceuticals, Ltd.|XTLB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda XTL Biopharmaceuticals|XTLB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi xtlbio.com|XTLB - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi XTL Biopharmaceuticals
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:xtlbio.com XTLB
Xavfsizlik zaxirasi yuqori bo'lgan aktivlarni qidirish bozor kapitalizatsiyasining daromadga nisbatini tahlil qilishdan boshlanadi. P/S koeffitsiyenti sotuvlarning har bir birligi tannarxini o'lchaydi, bu esa haqiqiy pul oqimlariga nisbatan haddan tashqari yuqori baholangan kutishlarni aniqlash imkonini beradi. XTL Biopharmaceuticals kompaniyasi uchun 12.70 qiymati tartibga soluvchi o'zgarishlar xavflarini minimallashtirgan holda, bioaktiv moddalarning taqsimotini monetizatsiya qilish samaradorligini aks ettiradi. Ushbu ko'rsatkichning narx-sotuv multiplikatori tarixidagi dinamikasi aksiyalarining adolatli qiymat nuqtasini aniqlashga yordam beradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA: Kapitalizatsiyaning daromadga nisbati|PTGX (Protagonist Corp) - Kapitalizatsiya va daromad nisbati|IMVT (Immunovant, Inc.) - Kapitalizatsiyaning daromadga nisbati|KNSA: Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Grifols|Narxning daromadga nisbati ADPT|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|veratx.com - Narxning daromadga nisbati|Dianthus Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Sotuvga nisbatan narx Tourmaline (TRML)|Narxning daromadga nisbati Precigen, Inc.|pharming.com - Narxning sotuvga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|P/S multiplikatori Immunome Bio IMNM|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|Septerna (SEPN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|SVRA (Savara Corp) - P/S multiplikatori|P/S multiplikatori Rigel Corp|P/S multiplikatori ANAB|Kapitalizatsiyaning daromadga nisbati astriatx.com ATXS|P/S multiplikatori ENGN (enGene)|RAPT Therapeutics Inc. (RAPT) - Sotuvga nisbatan narx|JBIO: Kapitalizatsiyaning daromadga nisbati|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|TLSA: Kapitalizatsiyaning sotish hajmiga nisbati|CABA (Cabaletta Bio) - P/S multiplikatori|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|Kapitalizatsiyaning daromadga nisbati Avalo Therapeutics Inc AVTX|P/S multiplikatori ELDN (Eledon Pharmaceuticals)|P/S multiplikatori agenusbio.com AGEN|CLYM - Narxning daromadga nisbati|ZURA: Narxning daromadga nisbati|aTyr (ATYR) - Narxning daromadga nisbati|ADAG - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati IMA|Kapitalizatsiya va daromad nisbati STTK (Shattuck Therapeutics)|Kapitalizatsiyaning daromadga nisbati EQ (Equillium, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati CNTB|Narxning daromadga nisbati Immunic IMUX|Atara Biotherapeutics, Inc. - Narxning daromadga nisbati|InflaRx GmbH - P/S multiplikatori|XFOR: Narxning daromadga nisbati|adicetbio.com (ACET) - Narxning daromadga nisbati|Narxning sotuvga nisbati CELU (Celularity)|INMB (INmune Bio Corp) - P/S multiplikatori|BRNS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KZR|P/S multiplikatori sabbiotherapeutics.com (SABS)|Narxning daromadga nisbati Akari Therapeutics Plc AKTX|Bozor kapitallashuvining daromadga nisbati ENLV|QTTB - Narxning daromadga nisbati|GeoVax Corp (GOVX) - Kapitalizatsiyaning daromadga nisbati|EDSA: P/S multiplikatori|ibioinc.com (IBIO) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CARM|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|Narx/daromad koeffitsiyenti aptevotherapeutics.com|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|Allakos - Kapitalizatsiyaning daromadga nisbati|HOOK: Kapitalizatsiya va daromad nisbati|IGMS: Kapitalizatsiyaning daromadga nisbati|iteostherapeutics.com - Kapitalizatsiyaning sotish hajmiga nisbati|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|TCBP (TC BioPharm (Holdings) Plc) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati THRD
